Endoscopic transgastric fenestration versus percutaneous drainage for management of (peri)pancreatic fluid collections adjacent to gastric wall (with video)

Table 1 Baseline characteristics

	ETGF (%)	PCD (%)	P value
Total	34	38
Male	24 (70.6)	26 (68.4)	0.84
Mean age	36.8 ± 12.9	46.0 ± 16.8	0.01
Mean length of lesions (mm)	109.4 ± 7.8	94.8 (80.8-133.2)	0.89
Cause of pancreastitis
Hyperlipidemia	10 (29.4)	8 (21.1)
Gallstone	8 (23.5)	8 (21.1)
Alcohol	9 (26.5)	6 (15.8)
Trauma	1 (2.9)	4 (10.5)
Autoimmunity	1 (2.9)	3 (7.9)
Pancreatic duct stones	3 (8.8)
Choledochocyst		1 (2.6)
Idiopathic	1 (2.9)	8 (21.1)
Clinical symptoms1
Abdominal pain (%)	24 (70.6)	27 (71.1)
Abdominal distention (%)	6 (17.65)	5 (13.2)
Nausea or vomiting	5	3
Fever	6	1
Asymptomatic	1	2
Preintervention	6	4
PCD	4	3
ETGF	1
Surgery	1	1
Opportunity of intervention2			0.381
< 4 wk	7	13
> 4 wk	21	24
Total interventions	1.03 ± 0.03	1.32 ± 0.09	0.003
Total hospital visits	1.0 (0)	1.0 (1.0)	0.278
Total hospital stays(days)	14.5 (10.25)	19.0 (20.5)	0.177
Total cost ($)	4852 (3877)	5206 (8377)	0.955

¹Multiple symptoms may coexist in one patient, so we didn't calculate percentages of each item.

²Here, we excluded patients that preintervention was inconsistent with original treatment in our hospital.

ETGF: Endoscopic transgastric fenestration; PCD: Percutaneous drainage.